Side-by-side comparison of AI visibility scores, market position, and capabilities
Baltimore largest US nuclear operator (NASDAQ: CEG) at $23.6B FY2024 revenue; 21 reactors, Three Mile Island restarted Sept 2024 for Microsoft AI data center, 24/7 carbon-free power competing with Vistra and NRG.
Constellation Energy Corporation is a Baltimore, Maryland-based clean energy company — publicly traded on NASDAQ (NASDAQ: CEG) as an S&P 500 Utilities component with a market capitalization of approximately $70 billion — operating the United States' largest fleet of carbon-free nuclear power plants with 21 nuclear reactors at 13 generating stations across Illinois, Pennsylvania, Maryland, New Jersey, and New York, through approximately 13,000 employees generating approximately 10% of all clean electricity in the United States. In fiscal year 2024, Constellation Energy reported revenue of $23.6 billion. Constellation was separated from Exelon Corporation in February 2022, when Exelon spun off its power generation business as an independent company while retaining the regulated utility subsidiaries (ComEd, PECO, BGE, Pepco, Delmarva, Atlantic City Electric). CEO Joe Dominguez leads Constellation's strategy of capitalizing on the AI data center electricity demand surge — nuclear power's unique combination of 24/7 carbon-free reliability makes Constellation the preferred clean power supplier for tech companies' 24/7 carbon-free electricity commitments that intermittent wind and solar cannot fulfill. Constellation's landmark achievement was the September 2024 restart of Three Mile Island Unit 1 (renamed Crane Clean Energy Center) — the reactor that operated safely for decades before closing in 2019 due to economic competition from cheap natural gas — under a 20-year power purchase agreement with Microsoft to supply the data center campus supporting Microsoft's Azure AI infrastructure in Pennsylvania.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.